Use your melon. There is no "good news" waiting in the wings. Most concerning of all, Ropren is in serious doubt, now. When people don't keep you informed, there is always a reason.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint